[Federal Register Volume 63, Number 164 (Tuesday, August 25, 1998)]
[Notices]
[Pages 45248-45249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-22718]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Current Science and Technology on Sprouts

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

     The Food and Drug Administration (FDA) is announcing the following 
meeting to review the current science, including technological and 
safety factors, relating to sprouts and to consider measures necessary 
to enhance the safety of these products.

    Date and Time: The meeting will be held on September 28 through 29, 
1998, 8:30 a.m. to 5 p.m.

    Location: The meeting will be held at Crowne Plaza Washington 
Hotel,

[[Page 45249]]

Sphinx Club Ballroom, 1375 K St. NW., Washington, DC.

     Contact: Catherine M. DeRoever, Center for Food Safety and Applied 
Nutrition (HFS-22), Food and Drug Administration, 200 C St. SW., 
Washington, DC 20204, 202-205-4251, FAX 202-205-4970, (e-mail) 
[email protected].

    Agenda: The purpose of this meeting is to provide a forum for 
discussion of the scope of the current situation, consumer 
perspectives, agricultural practices, the state of the science, and 
possible intervention strategies relating to sprouts.

    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number), to the contact person by September 11, 1998. Interested 
persons may present data, information, or views orally or in writing, 
on the issue. Written submissions must also be made to the contact 
person by September 11, 1998. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before September 11, 1998, and be prepared to 
give a brief statement of the general nature of the evidence you wish 
to present.
    If you need special accommodations due to a disability, please 
contact Ms. DeRoever at the above address at least 7 days in advance.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.

    Dated: August 18, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-22718 Filed 8-24-98; 8:45 am]
BILLING CODE 4160-01-F